These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 3631901)
1. Angioocclusive chemotherapy in melanoma: rationale and technical considerations. Voigt H; Löffler T Anticancer Res; 1987; 7(3 Pt B):443-4. PubMed ID: 3631901 [TBL] [Abstract][Full Text] [Related]
2. Impact of regional chemotherapy for melanoma metastases. Voigt H Anticancer Res; 1988; 8(3):347-9. PubMed ID: 2455471 [TBL] [Abstract][Full Text] [Related]
3. Spherex (degradable starch microspheres) chemo-occlusion--enhancement of tumor drug concentration and therapeutic efficacy: an overview. Håkansson L; Håkansson A; Morales O; Thorelius L; Warfving T Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-100-S6-109. PubMed ID: 9151924 [TBL] [Abstract][Full Text] [Related]
4. [Liver tumor targeting of drugs: Spherex, a vascular occlusive agent]. Taguchi T Gan To Kagaku Ryoho; 1995 Jun; 22(7):969-76. PubMed ID: 7794007 [TBL] [Abstract][Full Text] [Related]
5. Intraarterial chemotherapy of malignant melanoma metastatic to the liver. Melichar B; Dvorák J; Jandík P; Tousková M; Solichová D; Megancová J; Voboril Z Hepatogastroenterology; 2001; 48(42):1711-5. PubMed ID: 11813606 [TBL] [Abstract][Full Text] [Related]
6. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma. Nakamura Y; Nakamura Y; Hori E; Furuta J; Ishii Y; Takahashi T; Kawachi Y; Otsuka F Int J Dermatol; 2009 Jul; 48(7):763-7. PubMed ID: 19570088 [TBL] [Abstract][Full Text] [Related]
7. Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres. Taguchi T Clin Pharmacokinet; 1994 Apr; 26(4):275-91. PubMed ID: 8013161 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres. Rump AF; Woschée U; Theisohn M; Fischbach R; Heindel W; Lackner K; Klaus W Eur J Clin Pharmacol; 2002 Oct; 58(7):459-65. PubMed ID: 12389068 [TBL] [Abstract][Full Text] [Related]
10. [Phase I study on infusion of PJ-203 (degradable starch microspheres) into hepatic. PJ-203 Clinical Study Group]. Taguchi T Gan To Kagaku Ryoho; 1993 Sep; 20(12):1817-25. PubMed ID: 8379675 [TBL] [Abstract][Full Text] [Related]
11. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine. Melichar B; Voboril Z; Lojík M; Krajina A Hepatogastroenterology; 2009; 56(93):1157-62. PubMed ID: 19760961 [TBL] [Abstract][Full Text] [Related]
12. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. Serrone L; Zeuli M; Sega FM; Cognetti F J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932 [TBL] [Abstract][Full Text] [Related]
13. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage. Oldfield EH; Clark WC; Dedrick RL; Egorin MJ; Austin HA; DeVroom HD; Joyce KM; Doppman JL Cancer Res; 1987 Apr; 47(7):1962-7. PubMed ID: 3815385 [TBL] [Abstract][Full Text] [Related]
14. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma. Nuzzo C; Zeuli M; Ferraresi V; Ciccarese M; Pelligrini D; Cognetti F Anticancer Res; 2008; 28(2B):1429-31. PubMed ID: 18505091 [TBL] [Abstract][Full Text] [Related]
15. [Effective CDDP arterial infusion with DSM for liver metastasis of malignant melanoma complicating DIC due to intratumoral hemorrhage--a case report]. Takada K; Kato J; Kawano Y; Takahashi S; Hayashi T; Ishiwatari H; Miyanishi K; Takimoto R; Kobune M; Sagawa T; Sato T; Sato Y; Yamashita T; Natori H; Niitsu Y Gan To Kagaku Ryoho; 2008 Oct; 35(10):1803-5. PubMed ID: 18931594 [TBL] [Abstract][Full Text] [Related]
16. Curative and palliative aspects of regional chemotherapy in combination with surgery. Müller H; Hilger R Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948 [TBL] [Abstract][Full Text] [Related]
17. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization. Homma H; Doi T; Mezawa S; Takada K; Kukitsu T; Oku T; Akiyama T; Kusakabe T; Miyanishi K; Niitsu Y Cancer; 2000 Jul; 89(2):303-13. PubMed ID: 10918160 [TBL] [Abstract][Full Text] [Related]
18. [Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans]. Civalleri D; Esposito M; De Cian F; Balletto N; Vannozzi MO; Mondini G; Carrabetta S; Bocchio MM G Chir; 1997 Apr; 18(4):175-81. PubMed ID: 9303630 [TBL] [Abstract][Full Text] [Related]
19. Subcutaneous interleukin-2 and interferon-alpha therapy associated with cisplatin monochemotherapy in the treatment of metastatic melanoma. Andrès P; Cupissol D; Guillot B; Avril MF; Drèno B Eur J Dermatol; 1998 Jun; 8(4):235-9. PubMed ID: 9649695 [TBL] [Abstract][Full Text] [Related]
20. [Intrahepatic arterial infusion chemotherapy for the colon cancer patients with liver metastases--a comparison of arterial embolization chemotherapy versus continuous arterial infusion chemotherapy]. Tanada M; Saeki T; Takashima S; Mogami H; Hyoudou I; Jinno K Gan To Kagaku Ryoho; 1996 Sep; 23(11):1440-2. PubMed ID: 8854774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]